Cord blood is the blood present in the umbilical cord and placenta after the delivery of a newborn. Before the birth of the baby, stem cells and immune cells are transferred from the mother to the fetus in order to boost the immune systems of the mother and baby in preparation for labor. Thus, at the time of delivery, the blood in the umbilical cord is a rich source of stem cells and other cells of the immune system. [Read more…]
Cord Blood Registry (CBR®) by Generate Life Sciences Partners with NantKwest to Develop Covid-19 Treatment
CBR to Provide Umbilical Cord-Derived Cellular Material to NantKwest for additional COVID-19 Clinical Trials Utilizing MSC Therapy
Los Angeles, Calif., and El Segundo, Calif., August 10, 2020 – CBR® by Generate Life Sciences, the world’s largest private newborn stem cell bank, and NantKwest (Nasdaq: NK), a clinical-stage, natural killer cell-based immunotherapy company, announced a collaboration to develop a COVID-19 treatment leveraging newborn stem cells. CBR will provide research-donated umbilical cord tissue-derived mesenchymal stem cells (MSCs) to NantKwest for efficient and robust expansion utilizing their proprietary modular, closed bioreactor system from NantKwest affiliate ImmunityBio, Inc. [Read more…]
Cord Blood as a Therapeutic Strategy for Cerebral Palsy
Cerebral palsy is a neurological condition that affects thousands of babies born every year. Damage or malformation of the brain during development, most often in the womb, leads to motor and muscle symptoms. Children with cerebral palsy face a lifelong disability with consequences ranging from being wheelchair bound to painful, tight muscles and joints and even hearing loss, vision loss, cognitive deficits, and many more symptoms and complications that vary by individual. [Read more…]
Interview with the CEO of WideCells: Unlocking the Future of Cord Blood
CellPlan is a revolutionary stem cell insurance product launched by WideCells Group in Manchester, UK. WideCells Group aims to provide people with access to affordable stem cell treatments. In this interview, CEO  Joao Andrade describes how the company will facilitate the therapeutic use of umbilical cord blood stem cells by providing worldwide access to stem cell specialists and hospitals.
In this article:
Top 10 Quotes from the Perinatal Stem Cell Society Conference
Over the past three days, dozens of world renowned speakers have presented their latest findings at the Perinatal Stem Cell Society Conference, hosted by Kyle Cetrulo of Auxocell Laboratories and the Perinatal Stem Cell Society (IPLASS).
To capture the best moments from the conference, below are the top 10 quotes from the event, which was hosted at Aspen Meadows Resort in Aspen, CO,.
I took the image above as we were landing in Aspen. You can see our full photo album from the event on Flickr, featuring presenters, sponsors, and more. To get live updates from the event, connect with me on Twitter (@StemCellMarket) or follow the hashtag #Perinatal. Enjoy! [Read more…]
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 30
- Next Page »